Page last updated: 2024-10-23

bisindolylmaleimide i and Cancer of Pituitary

bisindolylmaleimide i has been researched along with Cancer of Pituitary in 3 studies

bisindolylmaleimide I: a bis(indolyl)maleimide

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nanzer, AM1
Khalaf, S1
Mozid, AM1
Fowkes, RC1
Patel, MV1
Burrin, JM1
Grossman, AB1
Korbonits, M1
Wang, YH2
Maurer, RA2
Jue, SF1

Other Studies

3 other studies available for bisindolylmaleimide i and Cancer of Pituitary

ArticleYear
Ghrelin exerts a proliferative effect on a rat pituitary somatotroph cell line via the mitogen-activated protein kinase pathway.
    European journal of endocrinology, 2004, Volume: 151, Issue:2

    Topics: Androstadienes; Animals; Butadienes; Carcinogens; Cell Division; Cell Line, Tumor; Dose-Response Rel

2004
A role for the mitogen-activated protein kinase in mediating the ability of thyrotropin-releasing hormone to stimulate the prolactin promoter.
    Molecular endocrinology (Baltimore, Md.), 1999, Volume: 13, Issue:7

    Topics: Animals; Binding Sites; Calcium; Calcium-Calmodulin-Dependent Protein Kinases; DNA-Binding Proteins;

1999
Thyrotropin-releasing hormone stimulates phosphorylation of the epidermal growth factor receptor in GH3 pituitary cells.
    Molecular endocrinology (Baltimore, Md.), 2000, Volume: 14, Issue:9

    Topics: Animals; Enzyme Inhibitors; ErbB Receptors; Genes, Reporter; Indoles; Luciferases; Maleimides; Mitog

2000